Weekly View

ICER Weekly View 08-18-17

From the desk of Mitchell Stein   Good morning. Before we get started, let’s take a minute to talk about the solar eclipse happening on Monday. During a week where the ugliness of humanity has been on display, I find it helps to pause and appreciate the wonder and majesty of the universe. It’s only […]

Read More

ICER Weekly View 08-11-17

From the desk of Mitchell Stein   Good morning. Another beautiful day here in Maine. I hope it’s equally nice where you are and everyone is enjoying their summer. Before we get to today’s news, a reminder that I welcome your feedback – both positive and negative. Now, on to the news: ICER in the news […]

Read More

ICER Weekly View 08-04-17

From the desk of Mitchell Stein   Good morning. The Senate passed a health care bill that the House has already passed. No, not that one, the FDA user fee bill. As the Senate joins the House on recess, we’ll look at: ICER in the news – Dr. Pearson on demand for info on effectiveness, […]

Read More

ICER Weekly View 07-28-17

From the desk of Mitchell Stein   Good morning. Waking up to dramatic news summed up by this tweet from Matthew Yglesias of Vox: “I guess John McCain finally read John McCain’s speech!” McCain’s vote puts to rest the Senate’s ACA repeal efforts (at least for today). Meanwhile, lots going on in the pharma world. […]

Read More

ICER Weekly View 07-21-17

From the desk of Mitchell Stein   Good morning. Here in Maine, I’m looking forward to the legendary Yarmouth Clam Festival coming up this weekend. (No, jokes today about the status of health reform, the reality is absurd enough.) Before I eat too much fried food, we’ll look at: ICER in the news – New CAR-T […]

Read More

ICER Weekly View 07-14-17

From the desk of Mitchell Stein   Good morning. Just a typical morning as we digest the latest Senate health care bill, the Medicare Trustee report, and 1600 pages of CMS payment proposals. Meanwhile, on the drug front, this week we’ll look at: ICER in the news – NY drug law, value framework, draft evidence […]

Read More

ICER Weekly View 07-07-17

From the desk of Mitchell Stein   Good morning. It may have been a short week for many of you, but we still have a lot to discuss. This week we’ll look at: ICER in the news – ICER’s Value Framework and the patient perspective, Sanofi Genzyme’s new chief, coverage of ICER’s work with […]

Read More

ICER Weekly View 06-30-17

From the desk of Mitchell Stein   Good morning. While many were focused on the continued ACA repeal efforts, the FDA was busy, and drug pricing continues to be a concern. No, I didn’t write this intro three months ago although I guess I could have. As many of us prepare for a long holiday […]

Read More

ICER Weekly View 06-23-17

From the desk of Mitchell Stein   Good morning. Did everyone have fun staying up late reading the Senate health care bill and the resulting avalanche of analysis? No, just me? Anyway, despite the focus on the latest repeal and replace developments, as always there is still lots to talk about in the pharma […]

Read More

ICER Weekly View 06-16-17

From the desk of Mitchell Stein   Good morning. Lots of ICER activity this week, so much in fact that there’s no “In-depth” feature so you have time to read about everything going on. Specifically, this week we’ll look at: ICER in the news – Wired magazine in-depth feature, Evidence Update on PCSK9 inhibitors along […]

Read More

Sign-up to have the Weekly View delivered to your inbox every Friday morning.

SIGN UP